Table 3 (Contd.)
exhibited significant advantages over the conventional heating
by not only reducing the reaction time, but also improving the
reaction yield.
In conclusion, we have developed a general, rapid and solvent-
free protocol for the synthesis of C6-funtionalized purine nucle-
osides between 6-halopurine analogues and mild nucleophiles,
which avoids the use of strong alkaline nucleophiles or the
introduction of efficient leaving groups. This method also has
several advantages such as mild reaction conditions, ease of
manipulation and a short reaction time. Furthermore, most of
the reactions involved are efficient, giving the desired compound
in higher purity and yield. Moreover, our eco-friendly solvent-
free method avoids the use of toxic solvents such as DMF,
DMSO, CH3CN and toluene. This environmentally friendly
procedure represents a promising green route for the syn-
thesis of these important C6-functionalized purine nucleoside
compounds.
Entry
9
Nucleophile
Product
Yieldb(%)
0
10
11
91
Acknowledgements
We are grateful for financial support from the National Nature
Science Foundation of China (grants 20772024, 20802016, and
21072047), the Program for New Century Excellent Talents
in University of Ministry of Education (NCET-09-0122), the
Program for Innovative Research Team in University of Henan
Province (2008IRTSTHN002), and the Henan National Nature
Science Foundation (092300410225).
78c
a Reaction conditions: 9-allyl-2,6-dichloro-9H-purine (1 mmol), nucle-
ophile (1.5 mmol), K2CO3 (2 mmol), MWI 400 W (90 ◦C). b Isolated
yields based on nucleobases. c Reaction time, 10 min.
Notes and references
1 (a) A. Brathe, L. L. Gundersen, F. Rise, A. B. Eriksen, A. V. Vollsnes
and L. Wang, Tetrahedron, 1999, 55, 211; (b) A. J. Cocuzza, D. R.
Chidester, S. Culp, L. Fitzgerald and P. Gilligan, Bioorg. Med. Chem.
Lett., 1999, 9, 1063; (c) D. E. Verdugo, M. T. Cancilla, X. Ge, N. S.
Gray, Y. T. Chang, P. G. Schultz, M. Negishi, J. A. Leary and C. R.
Bertozzi, J. Med. Chem., 2001, 44, 2683; (d) O. D. Perez, Y. T. Chang,
G. Rosania, D. Sutherlin and P. G. Schultz, Chem. Biol., 2002, 9, 475.
2 (a) A. E. Gibson, C. E. Arris, J. Bentley, F. T. Boyle, N. J. Curtin,
T. G. Davies, J. A. Endicott, B. T. Golding, H. Grant, R. J. Griffin,
P. Jewsbury, L. N. Johnson, V. Mesguiche, D. R. Newell, M. E. M.
Noble, J. A. Tucker and H. J. Whitfield, J. Med. Chem., 2002, 45, 3381;
(b) I. R. Hardcastle, C. E. Arris, J. Bentley, F. T. Boyle, Y. Chen, N. J.
Curtin, J. A. Endicott, A. E. Gibson, B. T. Golding, R. J. Griffin, P.
Jewsbury, J. Menyerol, V. Mesguiche, D. R. Newell, M. E. M. Noble,
D. J. Pratt, L. Z. Wang and H. J. Whitfield, J. Med. Chem., 2004, 47,
3710; (c) X. Chen, E. R. Kern, J. C. Drach, E. Gullen, Y. C. Cheng
and J. Zemlicka, J. Med. Chem., 2003, 46, 1531.
3 (a) M. R. Hamden and P. G. Wyatt, Tetrahedron Lett., 1990, 31, 2185;
(b) H. Roggen, C. Charnock and L. L. Gundersen, Tetrahedron, 2009,
65, 5199; (c) T. Kofoed, H. F. Hansen, H. Ørum and T. Koch, J. Pept.
Sci., 2001, 7, 402; (d) V. Nair, G. A. Turner and S. D. Chamberlain,
J. Am. Chem. Soc., 1987, 109, 7224; (e) E. A. Veliz and P. A. Beal,
J. Org. Chem., 2001, 66, 8592.
4 (a) S. Bae and M. K. Lakshman, J. Am. Chem. Soc., 2007, 129, 782;
(b) S. Bae and M. K. Lakshman, J. Org. Chem., 2008, 73, 1311; (c) Z. K.
Wan, S. Wacharasindhu, C. G. Levins, M. Lin, K. Tabei and T. S.
Mansour, J. Org. Chem., 2007, 72, 10194; (d) R. Fathi, B. Goswami,
P. P. Kung, B. L. Gaffney and R. A. Jones, Tetrahedron Lett., 1990, 31,
319; (e) Z. Janeba, X. Lin and M. J. Robins, Nucleosides, Nucleotides
Nucleic Acids, 2004, 23, 137; (f) N. K. Lembicz, S. Grant, W. Clegg,
R. J. Griffin, S. L. Heath and B. T. Golding, J. Chem. Soc., 1997, 1,
185; (g) V. Samano, T. R. W. Miles and M. J. Robins, J. Am. Chem.
Soc., 1994, 116, 9331; (h) G. T. Pauly, N. A. Loktionova, Q. Fang, S. L.
Vankayala, W. C. Guida and A. E. Pegg, J. Med. Chem., 2008, 51, 7144;
(i) R. Schirrmacher, U. Mu¨hlhausen, B. Wa¨ngler, E. Schirrmacher, J.
Reinhard, G. Nagel, B. Kaina, M. Piel, M. Wiebler and F. Rosch,
Tetrahedron Lett., 2002, 43, 6301.
conditions. Further screening of irradiation power showed that
400 W was the best choice.
To evaluate the generality of the reaction, a number of 6-
chloropurine derivatives with various substituents, including a
sugar carbon substituent at N9, were subjected to the optimized
reaction conditions, affording the desired 6-phenoxypurine
derivatives in good to excellent isolated yields (75–95%)
(Table 2). The type of substituent at N9 had a slight impact
on the yield of the products: the alkyl-substituted substrates
gave higher yields, while the sugar-substituted substrates gave
slightly lower yields.
Intrigued by the results described above, other substrates, such
as phenol, naphthol, thiophenol and aniline derivatives, were
chosen as mild nucleophiles to probe whether the nucleophilic
substitution reactions could be easily accessed. The results are
shown in Table 3. As expected, these reactions also proceeded
smoothly to give the corresponding 6-substituted purines in
good to high yields (78–97%) except that the desired product
4i could not be obtained even after 0.5 h, which might be due to
the strong steric hindrance of tert-butyl.
In order to compare the efficiency of microwave irradiation
with conventional heating, the formation of 4c was carried out
in an oil bath under the same conditions. It turned out that the
reaction afforded only 45% yield even after 24 h, far less than
the yield of 89% afforded under microwave irradiation within
5 min. This clearly indicated that the microwave-assisted reaction
This journal is
The Royal Society of Chemistry 2010
Green Chem., 2010, 12, 2131–2134 | 2133
©